Camp4 Therapeutics Corp - CAMP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 31, 2026 | SCHEDULE 13D/A | — | 9.98% | — | View |
| Aug 19, 2026 | SCHEDULE 13D/A | — | 1.0% | — | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BALYASNY ASSET MANAGEMENT L.P. | 4.99% | 2,591,097 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BAM GP LLC | 4.99% | 2,591,097 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Balyasny Asset Management Holdings LP | 4.99% | 2,591,097 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Dames GP LLC | 4.99% | 2,591,097 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Dmitry Balyasny | 4.99% | 2,591,097 | View |
| Aug 10, 2026 | SCHEDULE 13G | Trails Edge Capital Partners, LP | 6.0% | 3,790,636 | View |
| Aug 10, 2026 | SCHEDULE 13G | Trails Edge Biotechnology Master Fund, LP | 6.0% | 3,790,636 | View |
| Aug 10, 2026 | SCHEDULE 13G | Ortav Yehudai | 6.0% | 3,790,636 | View |
| Aug 05, 2026 | SCHEDULE 13D/A | — | 9.98% | — | View |
| May 15, 2026 | SCHEDULE 13G | Balyasny Asset Management L.P. | 5.07% | 2,632,437 | View |
| May 15, 2026 | SCHEDULE 13G | BAM GP LLC | 5.07% | 2,632,437 | View |
| May 15, 2026 | SCHEDULE 13G | Balyasny Asset Management Holdings LP | 5.07% | 2,632,437 | View |
| May 15, 2026 | SCHEDULE 13G | Dames GP LLC | 5.07% | 2,632,437 | View |
| May 15, 2026 | SCHEDULE 13G | Dmitry Balyasny | 5.07% | 2,632,437 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.